Jenburkt Pharmaceuticals Limited (BOM:524731)
India flag India · Delayed Price · Currency is INR
998.30
-2.00 (-0.20%)
At close: Mar 9, 2026

Jenburkt Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Cash & Equivalents
-73.6541.2536.650.3124.94
Upgrade
Short-Term Investments
-157.79698.44458.25415.55495.14
Upgrade
Cash & Short-Term Investments
96.48231.43739.69494.84465.86520.07
Upgrade
Cash Growth
-87.58%-68.71%49.48%6.22%-10.42%-4.67%
Upgrade
Accounts Receivable
-207.35194.75169.62152.07140.01
Upgrade
Other Receivables
-1150.0242.2821.3143.02
Upgrade
Receivables
-218.87245.67213.08175.28184.14
Upgrade
Inventory
-88.885.6683.3898.9876.17
Upgrade
Prepaid Expenses
-11.596.774.595.534.36
Upgrade
Other Current Assets
-14.6119.4915.0213.3915.13
Upgrade
Total Current Assets
-565.321,097810.91759.04799.87
Upgrade
Property, Plant & Equipment
-547.06112.14112.19113.05104.47
Upgrade
Long-Term Investments
-767.44173.9344.09415.71209.79
Upgrade
Goodwill
-----0.01
Upgrade
Other Intangible Assets
-2.283.881.873.064.8
Upgrade
Long-Term Deferred Tax Assets
-14.697.984.253.717.37
Upgrade
Other Long-Term Assets
-64.89255.51144.23133.5984.71
Upgrade
Total Assets
-1,9621,6511,4181,4291,212
Upgrade
Accounts Payable
-81.5562.5760.9771.145.92
Upgrade
Accrued Expenses
-16.049.312.552.5912.73
Upgrade
Short-Term Debt
-19.79-24.3958.1537.11
Upgrade
Current Portion of Leases
-4.23-4.894.514.17
Upgrade
Current Income Taxes Payable
-2.8616.413.370.772
Upgrade
Other Current Liabilities
-63.7275.4961.4675.6778
Upgrade
Total Current Liabilities
-188.19163.79157.62212.8179.92
Upgrade
Long-Term Leases
-14.92--4.899.4
Upgrade
Long-Term Deferred Tax Liabilities
-10.877.97.188.568.21
Upgrade
Other Long-Term Liabilities
-30.129.9129.4329.4329.65
Upgrade
Total Liabilities
-244.09201.59194.22255.67227.17
Upgrade
Common Stock
-44.1344.1344.1345.8945.89
Upgrade
Retained Earnings
-1,6571,3751,1651,119942.57
Upgrade
Comprehensive Income & Other
-16.7630.6215.259.2-3.8
Upgrade
Shareholders' Equity
1,8291,7181,4491,2241,174984.66
Upgrade
Total Liabilities & Equity
-1,9621,6511,4181,4291,212
Upgrade
Total Debt
17.0838.94-29.2867.5550.67
Upgrade
Net Cash (Debt)
79.41192.5739.69465.57398.31469.4
Upgrade
Net Cash Growth
-89.49%-73.98%58.88%16.89%-15.15%-4.92%
Upgrade
Net Cash Per Share
17.9943.62167.61101.9786.79102.28
Upgrade
Filing Date Shares Outstanding
4.414.414.414.414.594.59
Upgrade
Total Common Shares Outstanding
4.414.414.414.414.594.59
Upgrade
Working Capital
-377.12933.49653.29546.24619.95
Upgrade
Book Value Per Share
414.40389.23328.42277.32255.77214.55
Upgrade
Tangible Book Value
1,8251,7151,4461,2221,171979.85
Upgrade
Tangible Book Value Per Share
413.55388.71327.54276.90255.10213.50
Upgrade
Buildings
-117.96107.24103.86101.3996.73
Upgrade
Machinery
-237.32206.45193.64191.2178.46
Upgrade
Construction In Progress
-402.7712.419.572.123.78
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.